Inhibition of Selective Adhesion Molecules in Treatment of Inflammatory Bowel Disease
Author:
Publisher
Informa UK Limited
Subject
Immunology,Immunology and Allergy
Link
http://www.tandfonline.com/doi/pdf/10.3109/08830185.2012.690794
Reference90 articles.
1. Emerging drugs to treat Crohn’s disease
2. Intestinal epithelial cells in inflammatory bowel diseases
3. Overview of biologic therapy for Crohn's disease
4. Rheumatic manifestations of inflammatory bowel disease
5. A gut feeling of the PXR, PPAR and NF-κB connection
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. AJM300, a novel oral antagonist of α4‐integrin, sustains an increase in circulating lymphocytes: A randomised controlled trial in healthy male subjects;British Journal of Clinical Pharmacology;2020-01-28
2. Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti-β7 integrin therapy for inflammatory bowel disease;Alimentary Pharmacology & Therapeutics;2018-03-30
3. Pharmacokinetic and Pharmacodynamic Modeling of Serum Etrolizumab and Circulating β7 Receptor Occupancy in Patients With Ulcerative Colitis;The Journal of Clinical Pharmacology;2017-11-26
4. Biologic response modifiers: Indications, implications, and insights;Journal of Allergy and Clinical Immunology;2017-05
5. Eficacia y seguridad de vedolizumab en el tratamiento de la colitis ulcerosa;Gastroenterología y Hepatología;2016-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3